Get started
Author

Yoshio Tsujita

Observed names: Tsujita Yoshio, Y Tsujita, Y. TSUJITA, Y. Tsujita, YOSHIO TSUJITA, Yoshio TSUJITA
OpenAlex ID: A5111519067
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
1976 · AKIRA ENDO, MASAO KURODA, et al. · The Journal of Antibiotics · 969
PDF
CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
1986 · Yoshio Tsujita, Masao Kuroda, et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 374
Inhibition of Cholesterol Synthesis in vitro and in vivo by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A Reductase
1977 · Akira ENDO, Yoshio TSUJITA, et al. · European Journal of Biochemistry · 268
Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals
1979 · Endo Akira, Tsujita Yoshio, et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 215
WHHL‐Rabbit: a low density lipoprotein receptor‐deficient animal model for familial hypercholesterolemia
1980 · Kazuhiko Tanzawa, Yoko Shimada, et al. · FEBS Letters · 194
PDF
Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
1990 · Teiichiro Koga, Yohko Shimada, et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 169
Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic Plaques
1995 · Masashi Shiomi, Takashi Ito, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 127
PDF
Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase
1979 · Yoshio Tsujita, Masao Kuroda, et al. · Atherosclerosis · 113
Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits
1988 · Watanabe Yoshio, Ito Takashi, et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 101
The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats
1995 · Tomoyuki Fujioka, Futoshi Nara, et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 94
Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B)
1983 · NOBUFUSA SERIZAWA, KEIKO NAKAGAWA, et al. · The Journal of Antibiotics · 94
PDF
Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in triton WR-1339-induced hyperlipidemia
1977 · Masao Kuroda, Kazuhiko Tanzawa, et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 87
Hypolipidemic effects in monkeys of ML‐236B, a competitive inhibitor of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase
1979 · Masao Kuroda, Yoshio Tsujita, et al. · Lipids · 81
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits
1999 · Masashi Shiomi, Takashi Ito, et al. · Atherosclerosis · 63
Tissue selectivity of pravastatin sodium, lovastatin and simvastatin
1992 · Teiichiro KOGA, Kuniaki FUKUDA, et al. · European Journal of Biochemistry · 62
PDF
Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low
1990 · Masashi Shiomi, Takashi Ito, et al. · Atherosclerosis · 58
Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits
1993 · Masaharu Fukami, Naoyuki Maeda, et al. · Research in Experimental Medicine · 57
Hypolipidemic effects of CS-500 (ML-236B) in WHHL-rabbit, a heritable animal model for hyperlipidemia
1981 · Yoshio Watanabe, Takashi Ito, et al. · Atherosclerosis · 50
Epi-cochlioquinone A, a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor Produced by Stachybotrys bisbyi.
1996 · TOMOYUKI FUJIOKA, KEIKO YAO, et al. · The Journal of Antibiotics · 41
PDF
Biochemical Characterization of Skin Fibroblasts Derived from WHHL-Rabbit, a Notable Animal Model for Familial Hypercholesterolemia
1981 · Yoko SHIMADA, Kazuhiko TANZAWA, et al. · European Journal of Biochemistry · 41
PDF
3.ALPHA.-Hydroxy-ML-236B(3.ALPHA.-hydroxycompactin), microbial transformation product of ML-236B (compactin)
1983 · NOBUFUSAS ERIZAWA, KEIKO NAKAGAWA, et al. · The Journal of Antibiotics · 37
PDF
Purification and characterization of the two molecular forms of Aspergillus oryzae acid protease
1976 · Yoshio Tsujita, Akira Endo · Biochimica et Biophysica Acta (BBA) - Enzymology · 35
Schizostatin, a Novel Squalene Synthase Inhibitor Produced by the Mushroom, Schizophyllum commune. I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities.
1996 · TATSUO TANIMOTO, KAORI ONODERA, et al. · The Journal of Antibiotics · 34
PDF
Upregulation of Low Density Lipoprotein Receptor by Gemfibrozil, a Hypolipidemic Agent, in Human Hepatoma Cells Through Stabilization of mRNA Transcripts
1997 · Daisuke Goto, Tadayoshi Okimoto, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 29
PDF
Schizostatin, a Novel Squalene Synthase Inhibitor Produced by the Mushroom, Schizophylllum commune. II. Structure Elucidation and Total Synthesis.
1996 · HIROSHI KOGEN, KEIKO TAGO, et al. · The Journal of Antibiotics · 27
PDF
Works count: 72
Citation count: 3,757
H-index: 25
I10-index: 40
Year
Topic
Type